CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Chongqing Lummy Pharmaceutical Co Ltd Company Snapshot
Chongqing Lummy Pharmaceutical Co Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Chongqing Lummy Pharmaceutical Co Ltd with three other companies in this sector in CHINA : Shandong Shanda Wit Science and Technology Co Ltd (2019 sales of 1.80 billion Chinese Renmimbi [US$252.19 million] of which 60% was Medicines), Jinhe Biotechnology Co Ltd (1.78 billion Chinese Renmimbi [US$249.59 million] of which 91% was Domestic), and Shanghai Shenqi Pharmaceutical Investment Management CoLtd (1.93 billion Chinese Renmimbi [US$270.08 million] of which 75% was Pharmaceutical Manufacturing).

Sales Analysis. During the year ended December of 2019, sales at Chongqing Lummy Pharmaceutical Co Ltd were 1.86 billion Chinese Renmimbi (US$260.47 million). This is an increase of 19.0% versus 2018, when the company's sales were 1.56 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Chongqing Lummy Pharmaceutical Co Ltd (and since 2014, sales have increased a total of 104%). Sales of Chemical Distribution saw an increase that was more than double the company's growth rate: sales were up 8,876.0% in 2019, from 1.08 million Chinese Renmimbi to 97.16 million Chinese Renmimbi. Chongqing Lummy Pharmaceutical Co Ltd also saw significant increases in sales in Drug Sales Service (up 302.3% to 41.75 million Chinese Renmimbi) and Other Operations (up 438.4% to 19.83 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Chongqing Lummy Pharmaceutical Co Ltd
  Stock Performance Chart for Chongqing Lummy Pharmaceutical Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (5/29/2020): 4.82
(Figures in Chinese Renmimbi)
1 Week -0.8%   13 Weeks 1.9%  
4 Weeks -6.4%   52 Weeks -6.2%  
 
Chongqing Lummy Pharmaceutical Co Ltd Key Data:
  Ticker: 300006 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 1,859,010,760
(Year Ending Jan 2020).
Employees: 1,505
  Currency: Chinese Renmimbi Market Cap: 3,915,002,608
  Fiscal Yr Ends: December Shares Outstanding: 812,241,205
  Share Type: Gu Closely Held Shares:
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.